AUS
NZ
UK
CA
USA
IND
Healthcare
ASX Today 200 CSL and Pro Medicus Stand Out in Healthcare Sector
August 14, 2025 08:26 AM BST| By Team Kalkine MediaHighlights,CSL and Pro Medicus remain key names in healthcare,Different business models within the same sector,Both companies listed among ASX Today 200,The,ASX Today 200,features some of the most established and innovative companies in Australia, an...
FTSE 350 Companies Smith & Nephew (LSE:SN) Earnings Show Growth Despite Unusual Charges
August 12, 2025 02:38 PM BST| By Team Kalkine MediaHighlights,Smith & Nephew operates in the healthcare sector and is part of FTSE 350 Companies.,Recent earnings included significant one-time charges affecting net results.,Core earnings showed strong expansion, reflecting operational strength.,Smith...
FTSE 350 Index Smith & Nephew Performance in Medical Technology Sector
August 11, 2025 05:19 PM BST| By Team Kalkine MediaHighlights,Smith & Nephew PLC operates within the medical technology sector with a multi-division portfolio,Orthopaedics division shows contrasting trends between hip and knee procedures in the US,Sports Medicine and Wound Management divisions expand...
FTSE All Share Diaceutics PLC (LSE:DXRX) Ownership and Sector Position
August 11, 2025 04:54 PM BST| By Team Kalkine MediaHighlights,Operates in the healthcare diagnostics sector with strong institutional presence,Notable executive shareholding creating management-shareholder alignment,Included in the FTSE All Share index with concentrated ownership among key stakeholde...
ftse 350: GSK Receives Priority for Oral Gonorrhoea Treatment
August 11, 2025 11:36 AM BST| By Team Kalkine MediaHighlights,US FDA accepts application for a new oral gonorrhoea treatment,Gepotidacin developed as an alternative to injectable therapies,Regulatory submissions also underway in other regions,ftse 350,company GSK (LON:GSK) operates within the global...
First Market Update as FTSE 100 Shows Mixed Moves but Calm Sentiment Persists
August 11, 2025 10:41 AM BST| By Team Kalkine MediaHighlights,FTSE 100 and FTSE 350 see soften during a subdued trading session.,Key sectors including blue-chip stocks exhibit steady performance amid limited market drivers.,Market atmosphere remains relaxed as investors await further economic.,The bl...
ftse 250 companies: Faron Pharmaceuticals Pursues Advancements in Immunotherapy
August 09, 2025 12:45 PM BST| By Team Kalkine MediaHighlights,Faron Pharmaceuticals focuses on developing innovative cancer immunotherapies,Bexmarilimab targets Clever-1 to reshape the immune response in tumour environments,Operational progress includes intellectual property protection and clinical-s...
GSK plc (LSE:GSK) Dividend Performance within the Pharmaceutical Sector of the FTSE 350
August 09, 2025 12:11 PM BST| By Team Kalkine MediaHighlights,GSK plc is a major entity in the pharmaceutical sector and a constituent of the FTSE 350 index.,Dividend payouts represent a significant share of earnings and free cash flow.,The current dividend yield is approximately relative to the shar...
FTSE 100 Healthcare Company Smith & Nephew (LSE:SN) Reports Increased Cash Flow and Launches Buyback
August 05, 2025 08:33 AM BST| By Team Kalkine MediaHighlights,Smith & Nephew posts increase in operating cash flow and underlying earnings for the recent period.,A share buyback programme is launched following first-half financial results.,The company continues operational focus across orthopaedics,...
FTSE All Share Scancell Holdings (LSE:SCLP) Share Transaction Highlights Strategic Stake Acquisition
August 05, 2025 07:36 AM BST| By Team Kalkine MediaHighlights,Share transaction recorded involving Scancell Holdings.,Transaction details disclosed through official filing.,Company maintains activity in the cancer immunotherapy space.,Scancell Holdings operates within the healthcare and biotechnology...
FTSE 100 Healthcare Firm Convatec Group (LSE:CTEC) Advances Global Medical Technologies
August 01, 2025 10:26 AM BST| By Team Kalkine MediaHighlights,Convatec Group delivers medical products and technology solutions across multiple categories.,Operational structure spans wound care, ostomy, continence, and infusion devices.,Company maintains a global presence with manufacturing and dist...
hVIVO (LSE:HVO) Receives New Rating in Biotech Sector Development
July 31, 2025 08:56 AM BST| By Team Kalkine MediaHighlights,hVIVO is a biotechnology firm specializing in human challenge clinical trials.,Peel Hunt issued an "Add" rating for hVIVO in its latest market release.,The company continues to expand its facilities and trial service offerings.,hVIVO (LSE:...
FTSE 100 Sees Movement as AstraZeneca (LSE:AZN) Headlines Earnings, Eurozone GDP in Focus
July 30, 2025 12:14 PM BST| By Team Kalkine MediaHighlights,AstraZeneca releases financial results influencing FTSE 100 performance.,Eurozone GDP updates coincide with activity across major UK-listed companies.,Market attention remains on corporate releases and broader economic signals.,AstraZeneca...
GlaxoSmithKline FTSE 100 Pharmaceutical Firm (LSE:GSK) Advances Product Pipeline
July 30, 2025 12:00 AM BST| By Team Kalkine MediaHighlights,GlaxoSmithKline PLC saw strong performance across its Specialty Medicines and Vaccines divisions.,The company advanced its research and development pipeline with multiple regulatory milestones.,GSK is part of the FTSE 100, representing one...
FTSE 100 Momentum Builds as AstraZeneca (LSE:AZN) Delivers in Healthcare Sector
July 29, 2025 11:52 AM BST| By Team Kalkine MediaHighlights,AstraZeneca impacts FTSE 100 index movement through recent financial reporting.,Performance across the pharmaceutical segment reflects steady operating progress.,Broader index activity shows alignment with healthcare sector outcomes.,Astra...
Oxford Nanopore Technologies Ltd (LSE:ONT) Scales Molecular Platforms Through FTSE 250 Companies
July 29, 2025 12:00 AM BST| By Team Kalkine MediaHighlights,Oxford Nanopore Technologies Ltd develops sequencing platforms for real-time molecular analysis.,The company offers scalable systems for use in research, diagnostics, and scientific exploration.,It is part of the,FTSE 250 Companies,, posit...
AstraZeneca (LSE:AZN) Strengthens Position with FTSE 100 Sector Alignment
July 29, 2025 12:00 AM BST| By Team Kalkine MediaHighlights,AstraZeneca PLC continues to deliver within the pharmaceutical sector with momentum across multiple therapy areas.,The company demonstrates strategic positioning in the FTSE 100 through expansion in oncology and biopharmaceutical capabilit...
Hemogenyx Pharmaceuticals PLC (LSE:HEMO) Advances Biotechnology Focus on Blood Therapies
July 29, 2025 12:00 AM BST| By Team Kalkine MediaHighlights,Hemogenyx Pharmaceuticals develops therapeutic technologies targeting blood diseases at the preclinical stage.,The company maintains strong liquidity supported by high current and quick ratios.,Listed on the LSE, Hemogenyx Pharmaceuticals...
Is FTSE 100 Pharma Stock GSK (LSE:GSK) Expanding Its China Strategy?
July 28, 2025 08:59 AM BST| By Team Kalkine MediaHighlights,GSK to pay an upfront amount for a licensing deal with Chinese firm.,Agreement includes development and commercial rights to Bellberry’s siRNA treatment.,Strategic focus on respiratory treatments targeting diseases with limited therapeutic...
How Is GlaxoSmithKline PLC (LSE:GSK) Advancing in the FTSE All Share Healthcare Sector?
July 28, 2025 12:00 AM BST| By Team Kalkine MediaHighlights,GlaxoSmithKline PLC has entered into a development agreement involving multiple experimental medicines.,The collaboration introduces a dry-powder inhaler aimed at addressing inflammation and airway tightening.,The company is a constituent...
